The global infertility treatment devices and equipment market size was valued at USD 206. 7 million in 2018 and is expected to expand at a CAGR of 9.3% over the forecast period. Rising prevalence of conditions such as Polycystic Ovary Syndrome (PCOS). Significant changes in lifestyle are anticipated to contribute to the rise in infertility. Increasing preference of working women for conceiving at a later age may lead to complications. Infertility in men is a result of various factors such as stress, alcohol tobacco consumption, smoking, changing lifestyle, and reducing sperm count and motility. A constant increase in the incidence of infertility in both sexes is projected to drive the market.
Various government initiatives and changes in the legal system are among the factors driving the demand for assisted reproduction procedures. In the U.S., around 14 states cover infertility treatment under medical insurance. In Canada, the government is initiating measures to control the declining population, wherein it has sponsored various cycles of artificial insemination and In Vitro Fertilization (IVF).
Innovation and enhanced technologies are expected to boost the market growth in the forthcoming years. Advancements in technology increase the success rate of procedures. For instance, the development of storage equipment for temperature-sensitive sperm samples will result in increasing demand for cryosystems and other related devices.
Advancements in assisted reproductive treatments offer numerous options for patients seeking out help for infertility treatment. Time-lapse imaging is the latest innovative technologies in infertility treatments. Time-lapse imaging can be used to examine the embryo development process at regular intervals without disturbing the culture. In the previous monitoring methods, embryos would be removed from the incubator daily to be analyzed. The technology and use of computers allow the embryos to stay in the incubator without disrupting its development.
In 2018, sperm separation devices held a majority of the share in the infertility treatment devices and equipment market. Sperm separation devices are used in most of the ARTs such as IVF and artificial insemination. These devices are crucial for ARTs as they provide purified samples for further procedures.
Imaging systems, on the other hand, are expected to witness the fastest growth over the forecast period, owing to the introduction of time-lapse monitoring technology. Time-lapse monitoring can be used to assess the potential of the embryo for implanting. The non-invasive time-lapse technology generates images of the embryo development with the morphologic changes.
In 2018, fertility clinics held the largest market share. The number of medical centers providing treatment for infertility has increased over the past few years due to an increase in the prevalence of infertility across the world. Crucial treatments, such as IVF and intrauterine insemination, are performed in specialized fertility clinics. Moreover, fertility clinics also provide counseling for couples trying to start a family.
Fertility clinics must comply with specific guidelines to operate in certain regions. In order to obtain the licenses in specific countries, fertility clinics need to fulfill all the requirements presented by the regulatory agencies in respective countries.
Europe held the majority of the market share in 2018 as the fertility rate in the region has been decreasing over the years. Delay in pregnancy and lifestyle changes are among factors contributing to this decline. North America was the second-largest market in 2018 as the fertility rate in the U.S. was at a record low. There were only 62.5 births per 1,000 women, according to the National Center for Health Statistics.
Asia Pacific is expected to witness the fastest growth in the forthcoming years due to an increase in the infertility rate in this region and awareness about available treatment options. The availability of various reimbursement schemes in developed regions is likely to further fuel the regional expansion. For instance, the Singapore government offers around 75% co-funding for various ART procedures.
Some of the key market players are The Cooper Companies, Inc.; Hamilton Thorne, Inc.; Cook; Vitrolife; DxNow, Inc.; etc. These market players are adopting strategies such as acquisitions to strengthen their presence in other regional markets. For instance, The Cooper Companies, Inc. acquired LifeGlobal Group and its affiliates in April 2018. The company also acquired PARAGARD IUD business from Teva in November 2017 and Wallace product line from Smiths Group in November 2016.
CooperSurgical competes in the global infertility market with a product portfolio of IVF media and ART solutions to help the work of infertility specialists. The Cooper Companies, Inc., the parent company of CooperSurgical, has expanded the business through the acquisition of companies and product lines within the fertility space. CooperSurgical offers a wide variety of products ranging from ART workstations, micromanipulator systems, temperature control systems, air purification systems, incubators, sperm analyzer systems, sperm separation systems, and microscopes.
Attribute |
Details |
Base year for estimation |
2018 |
Actual estimates/Historical data |
2015 - 2018 |
Forecast period |
2019 - 2026 |
Market representation |
Revenue in USD Million & CAGR from 2019 to 2026 |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, Colombia, South Africa, Saudi Arabia, United Arab Emirates |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors & trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global infertility treatment devices and equipment market based on type, end-use, and region:
Type Outlook (Revenue, USD Million, 2015 - 2026)
Ovum Aspiration Pumps
Sperm Separation Devices
Sperm Analyzer Systems
Micromanipulator Systems
Incubators
Cryosystems
Imaging Systems
Microscopes
Others
End-Use Outlook (Revenue, USD Million, 2015 - 2026)
Fertility Clinics
Hospitals & Other Healthcare Facilities
Clinical Research Institutes
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
United Arab Emirates
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.